Skip to main content
SpringerLink
Log in

Determinants of the prevalence of gout in the general population: a systematic review and meta-regression

  • REVIEW
  • Published:
European Journal of Epidemiology Aims and scope Submit manuscript

Abstract

Studies on the occurrence of gout show a large range in estimates. However, a clear insight into the factors responsible for this variation in estimates is lacking. Therefore, our aim was to review the literature on the prevalence and incidence of gout systematically and to obtain insight into the degree of and factors contributing to the heterogeneity. We searched MEDLINE, EMBASE, and Web of Science (January 1962 to July 2012) to identify primary studies on the prevalence and incidence of gout in the general population. Data were extracted by two persons on sources of clinical heterogeneity, methodological heterogeneity, and variation in outcome reporting. Meta-analysis and meta-regression analysis were performed for the prevalence of gout. Of 1,466 articles screened, 77 articles were included, of which 71 reported the prevalence and 12 the incidence of gout. The pooled prevalence (67 studies; N = 12,226,425) based on a random effects model was 0.6 % (95 % CI 0.4; 0.7), however there was a high level of heterogeneity (I2 = 99.9 %). Results from a mixed-effects meta-regression model indicated that age (p = 0.019), sex (p < 0.001), continent (p < 0.001), response rate (p = 0.016), consistency in data collection (p = 0.002), and case definition (p < 0.001) were significantly associated with gout prevalence and jointly accounted for 88.7 % of the heterogeneity. The incidence in the total population ranged from 0.06 to 2.68 per 1,000 person-years. In conclusion, gout is a common disease and the large variation in the prevalence data on gout is explained by sex, continent on which the study was performed, and the case definition of gout.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Zhu Y, Pandya BJ, Choi HK. Comorbidities of gout and hyperuricemia in the US general population: NHANES 2007–2008. Am J Med. 2012;125:679–87. doi:10.1016/j.amjmed.2011.09.033.

    PubMed  Google Scholar 

  2. Roddy E, Zhang W, Doherty M. Is gout associated with reduced quality of life? A case-control study. Rheumatology. 2007;46:1441–4.

    CAS  PubMed  Google Scholar 

  3. Hamburger M, Baraf HS, Adamson TC 3rd, Basile J, Bass L, Cole B, et al. 2011 Recommendations for the diagnosis and management of gout and hyperuricemia. Postgrad Med. 2011;123:3–36. doi:10.3810/pgm.2011.11.2511.

    PubMed  Google Scholar 

  4. Saag KG, Choi H. Epidemiology, risk factors, and lifestyle modifications for gout. Arthritis Res Ther. 2006;8:S2.

    PubMed Central  PubMed  Google Scholar 

  5. Singh JA. Racial and gender disparities among patients with gout. Curr Rheumatol Rep. 2013;15:307. doi:10.1007/s11926-012-0307-x.

    PubMed Central  PubMed  Google Scholar 

  6. Doherty M. New insights into the epidemiology of gout. Rheumatology. 2009;48:2–8.

    Google Scholar 

  7. Luk AJ, Simkin PA. Epidemiology of hyperuricemia and gout. Am J Manag Care. 2005;11:S435–42.

    PubMed  Google Scholar 

  8. Miller DR, Rogers WH, Kazis LE, Spiro A 3rd, Ren XS, Haffer SC. Patients’ self-report of diseases in the Medicare Health Outcomes Survey based on comparisons with linked survey and medical data from the Veterans Health Administration. J Ambul Care Manage. 2008;31:161–77. doi:10.1097/01.JAC.0000314707.88160.9c.

    PubMed  Google Scholar 

  9. Malik A, Dinnella JE, Kwoh CK, Schumacher HR. Poor validation of medical record ICD-9 diagnoses of gout in a Veterans Affairs Database. J Rheumatol. 2009;36:1283–6.

    PubMed  Google Scholar 

  10. Cheng LSC, Chiang SL, Tu HP, Chang SJ, Wang TN, Ko AMJ, et al. Genomewide scan for gout in Taiwanese aborigines reveals linkage to chromosome 4q25. Am J Hum Genet. 2004;75:498–503.

    CAS  PubMed  Google Scholar 

  11. Sutton AJ, Abrams KR, Jones DR, Sheldon TA, Song F. Methods for meta-analysis in medical research. New York: Wiley; 2000.

    Google Scholar 

  12. Lipsey MW, Wilson DB. Practical meta-analysis. Thousand Oaks, CA: Sage; 2001.

    Google Scholar 

  13. Riley RD, Higgins JP, Deeks JJ. Interpretation of random effects meta-analyses. BMJ. 2011;342:d549. doi:10.1136/bmj.d549.

    PubMed  Google Scholar 

  14. Berkey CS, Hoaglin DC, Mosteller F, Colditz GA. A random-effects regression model for meta-analysis. Stat Med. 1995;14:395–411.

    CAS  PubMed  Google Scholar 

  15. Greenland S, O’Rourke K. On the bias produced by quality scores in meta-analysis, and a hierarchical view of proposed solutions. Biostatistics. 2001;2:463–71. doi:10.1093/biostatistics/2.4.463.

    CAS  PubMed  Google Scholar 

  16. Raudenbush SW. Analyzing effect sizes: random-effects models. In: Cooper H, Hedges LV, Valentine JC, editors. The handbook of research synthesis and meta-analysis. 2nd ed. New York: Russell Sage Foundation; 2009. p. 295–315.

    Google Scholar 

  17. Knapp G, Hartung J. Improved tests for a random effects meta-regression with a single covariate. Stat Med. 2003;22:2693–710. doi:10.1002/sim.1482.

    PubMed  Google Scholar 

  18. Holm S. A simple sequentially rejective multiple test procedure. Scand J Statist. 1979;6:65–70.

    Google Scholar 

  19. Viechtbauer W. Conducting meta-analyses in R with the metafor Package. J Stat Softw. 2010;36:1–48.

    Google Scholar 

  20. Bates D, Maechler M, Bolker B, Walker S. lme4: Linear mixed-effects models using Eigen and S4. R package version 1.1–6 2014. http://CRAN.R-project.org/package=lme4.

  21. Yee TW. The VGAM package for categorical data analysis. J Stat Softw. 2010;32:1–34.

    Google Scholar 

  22. Akizuki S. A population study of hyperuricaemia and gout in Japan–analysis of sex, age and occupational differences in thirty-four thousand people living in Nagano Prefecture. Ryumachi. 1982;22:201–8.

    CAS  PubMed  Google Scholar 

  23. Al-Arfaj AS. Hyperuricemia in Saudi Arabia. Rheumatol Int. 2001;20:61–4.

    CAS  PubMed  Google Scholar 

  24. Alvarez Nemegyei J, Nuno Gutierrez BL, Alcocer Sanchez JA. Enfermedades reumaticas y discapacidad laboral en poblacion adulta rural. Rev Med Inst Mex Seguro Soc. 2005;43:287–92.

    PubMed  Google Scholar 

  25. Anagnostopoulos I, Zinzaras E, Alexiou I, Papathanasiou AA, Davas E, Koutroumpas A, et al. The prevalence of rheumatic diseases in central Greece: a population survey. BMC Musculoskelet Disord. 2010;11:98. doi:10.1186/1471-2474-11-98.

    PubMed Central  PubMed  Google Scholar 

  26. Andrianakos A, Trontzas P, Christoyannis F, Dantis P, Voudouris C, Georgountzos A, et al. Prevalence of rheumatic diseases in Greece: a cross-sectional population based epidemiological study. The ESORDIG Study. J Rheumatol. 2003;30:1589–601.

    PubMed  Google Scholar 

  27. Annemans L, Spaepen E, Gaskin M, Bonnemaire M, Malier V, Gilbert T, et al. Gout in the UK and Germany: prevalence, comorbidities and management in general practice 2000–2005. Ann Rheum Dis. 2008;67:960–6.

    PubMed Central  CAS  PubMed  Google Scholar 

  28. Badley EM, Meyrick JS, Wood PH. Gout and serum uric acid levels in the Cotswolds. Rheumatol Rehabil. 1978;17:133–42.

    CAS  PubMed  Google Scholar 

  29. Beighton P, Solomon L, Soskolne CL, Sweet MB. Rheumatic disorders in the South African Negro. Part IV. Gout and hyperuricaemia. S Afr Med J. 1977;51:969–72.

    CAS  PubMed  Google Scholar 

  30. Beighton P, Valkenburg HA. Bone and joint disorders on Tristan da Cunha. S Afr Med J. 1974;48:743–7.

    CAS  PubMed  Google Scholar 

  31. Bergmann MM, Jacobs EJ, Hoffmann K, Boeing H. Agreement of self-reported medical history: comparison of an in-person interview with a self-administered questionnaire. Eur J Epidemiol. 2004;19:411–6.

    PubMed  Google Scholar 

  32. Bergstrom G, Bjelle A, Sorensen LB, Sundh V, Svanborg A. Prevalence of rheumatoid arthritis, osteoarthritis, chondrocalcinosis and gouty arthritis at age 79. J Rheumatol. 1986;13:527–34.

    CAS  PubMed  Google Scholar 

  33. Boyer GS, Lanier AP, Templin DW. Prevalence rates of spondyloarthropathies, rheumatoid arthritis, and other rheumatic disorders in an Alaskan Inupiat Eskimo population. J Rheumatol. 1988;15:678–83.

    CAS  PubMed  Google Scholar 

  34. Brauer GW, Prior IA. A prospective study of gout in New Zealand Maoris. Ann Rheum Dis. 1978;37:466–72.

    PubMed Central  CAS  PubMed  Google Scholar 

  35. Cakir N, Pamuk ON, Dervis E, Imeryuz N, Uslu H, Benian O, et al. The prevalences of some rheumatic diseases in western Turkey: Havsa study. Rheumatol Int. 2012;32:895–908. doi:10.1007/s00296-010-1699-4.

    PubMed  Google Scholar 

  36. Cardiel MH, Rojas-Serrano J. Community based study to estimate prevalence, burden of illness and help seeking behavior in rheumatic diseases in Mexico City. A COPCORD study. Clin Exp Rheumatol. 2002;20:617–24.

    CAS  PubMed  Google Scholar 

  37. Chaiamnuay P, Darmawan J, Muirden KD, Assawatanabodee P. Epidemiology of rheumatic disease in rural Thailand: a WHO-ILAR COPCORD study. Community Oriented Programme for the Control of Rheumatic Disease. J Rheumatol. 1998;25:1382–7.

    CAS  PubMed  Google Scholar 

  38. Chang SJ, Ko YC, Wang TN, Chang FT, Cinkotai FF, Chen CJ. High prevalence of gout and related risk factors in Taiwan’s Aborigines. J Rheumatol. 1997;24:1364–9.

    CAS  PubMed  Google Scholar 

  39. Chen SL, Du H, Wang Y, Xu LQ. The epidemiology study of hyperuricemia and gout in a community population of Huangpu District in Shanghai. Chin Med J. 1998;111:228–30.

    CAS  PubMed  Google Scholar 

  40. Chopra A, Patil J, Billempelly V, Relwani J, Tandle HS. Prevalence of rheumatic diseases in a rural population in western India: a WHO-ILAR COPCORD Study. J Assoc Physicians India. 2001;49:240–6.

    CAS  PubMed  Google Scholar 

  41. Chou CT, Lai JS. The epidemiology of hyperuricaemia and gout in Taiwan aborigines. Br J Rheumatol. 1998;37:258–62.

    CAS  PubMed  Google Scholar 

  42. Chou CT, Pei L, Chang DM, Lee CF, Schumacher HR, Liang MH. Prevalence of rheumatic diseases in Taiwan: a population study of urban, suburban, rural differences. J Rheumatol. 1994;21:302–6.

    CAS  PubMed  Google Scholar 

  43. Chuang SY, Lee SC, Hsieh YT, Pan WH. Trends in hyperuricemia and gout prevalence: nutrition and health survey in Taiwan from 1993–1996 to 2005–2008. Asia Pac J Clin Nutr. 2011;20:301–8.

    CAS  PubMed  Google Scholar 

  44. Currie WJ. Prevalence and incidence of the diagnosis of gout in Great Britain. Ann Rheum Dis. 1979;38:101–6.

    PubMed Central  CAS  PubMed  Google Scholar 

  45. Dai SM, Han XH, Zhao DB, Shi YQ, Liu Y, Meng JM. Prevalence of rheumatic symptoms, rheumatoid arthritis, ankylosing spondylitis, and gout in Shanghai, China: a COPCORD study. J Rheumatol. 2003;30:2245–51.

    PubMed  Google Scholar 

  46. Dans LF, TankehTorres S, Amante CM, Penserga EG. The prevalence of rheumatic diseases in a Filipino urban population: a WHO-ILAR COPCORD study. J Rheumatol. 1997;24:1814–9.

    CAS  PubMed  Google Scholar 

  47. Darmawan J, Valkenburg HA, Muirden KD, Wigley RD. The epidemiology of gout and hyperuricemia in a rural population of Java. J Rheumatol. 1992;19:1595–9.

    CAS  PubMed  Google Scholar 

  48. Davatchi F, Jamshidi AR, Banihashemi AT, Gholami J, Forouzanfar MH, Akhlaghi M, et al. Effect of ethnic origin (Caucasians versus Turks) on the prevalence of rheumatic diseases: a WHO-ILAR COPCORD urban study in Iran. Clin Rheumatol. 2009;28:1275–82.

    PubMed  Google Scholar 

  49. Douglas WA. Rheumatic disease in the Australian Aborigine of Cape York Peninsula: a 1965 study. APLAR J Rheumatol. 2004;7:237–41. doi:10.1111/j.1479-8077.2004.00098.x.

    Google Scholar 

  50. Elliot AJ, Cross KW, Fleming DM. Seasonality and trends in the incidence and prevalence of gout in England and Wales 1994–2007. Ann Rheum Dis. 2009;68:1728–33.

    CAS  PubMed  Google Scholar 

  51. Farooqi A, Gibson T. Prevalence of the major rheumatic disorders in the adult population of north Pakistan. Br J Rheumatol. 1998;37:491–5.

    CAS  PubMed  Google Scholar 

  52. Gardner MJ, Power C, Barker DJ, Padday R. The prevalence of gout in three English towns. Int J Epidemiol. 1982;11:71–5.

    CAS  PubMed  Google Scholar 

  53. Hall AP, Barry PE, Dawber TR, McNamara PM. Epidemiology of gout and hyperuricemia. A long-term population study. Am J Med. 1967;42:27–37.

    CAS  PubMed  Google Scholar 

  54. Hanova P, Pavelka K, Dostal C, Holcatova I, Pikhart H. Epidemiology of rheumatoid arthritis, juvenile idiopathic arthritis and gout in two regions of the Czech Republic in a descriptive population-based survey in 2002–2003. Clin Exp Rheumatol. 2006;24:499–507.

    CAS  PubMed  Google Scholar 

  55. Haq SA, Darmawan J, Islam MN, Uddin MZ, Das BB, Rahman F, et al. Prevalence of rheumatic diseases and associated outcomes in rural and urban communities in Bangladesh: a COPCORD study. J Rheumatol. 2005;32:348–53.

    PubMed  Google Scholar 

  56. Harris CM, Lloyd D, Lewis J. Prevalence and Prophylaxis of Gout in England. J Clin Epidemiol. 1995;48:1153–8.

    CAS  PubMed  Google Scholar 

  57. Hoa TTM, Damarwan J, Le CS, Hung NV, Nhi CT, An TN. Prevalence of the rheumatic diseases in urban Vietnam: a WHO-ILAR COPCORD study. J Rheumatol. 2003;30:2252–6.

    Google Scholar 

  58. Jackson L, Taylor R, Faaiuso S, Ainuu SP, Whitehouse S, Zimmet P. Hyperuricaemia and gout in Western Samoans. J Chronic Dis. 1981;34:65–75.

    CAS  PubMed  Google Scholar 

  59. Joshi VL, Chopra A. Is there an urban-rural divide? Population surveys of rheumatic musculoskeletal disorders in the Pune region of India using the COPCORD Bhigwan Model. J Rheumatol. 2009;36:614–22.

    PubMed  Google Scholar 

  60. Kato H, Duff IF, Russell WJ, Uda Y, Hamilton HB, Kawamoto S, et al. Rheumatoid arthritis and gout in Hiroshima and Nagasaki, Japan: a prevalence and incidence study. J Chronic Dis. 1971;23:659–79.

    CAS  PubMed  Google Scholar 

  61. Klemp P, Stansfield SA, Castle B, Robertson MC. Gout is on the increase in New Zealand. Ann Rheum Dis. 1997;56:22–6.

    PubMed Central  CAS  PubMed  Google Scholar 

  62. Kramer HM, Curhan G. The association between gout and nephrolithiasis: the National Health and Nutrition Examination Survey III, 1988–1994. Am J Kidney Dis. 2002;40:37–42.

    PubMed  Google Scholar 

  63. Li R, Sun J, Ren LM, Wang HY, Liu WH, Zhang XW, et al. Epidemiology of eight common rheumatic diseases in China: a large-scale cross-sectional survey in Beijing. Rheumatology. 2012;51:721–9. doi:10.1093/rheumatology/ker370.

    PubMed  Google Scholar 

  64. Mahajan A, Jasrotia DS, Manhas AS, Jamwal SS. Prevalence of major rheumatic disorders in Jammu. JK Sci. 2003;5:63–6.

    Google Scholar 

  65. Miao ZM, Li CG, Chen Y, Zhao SH, Wang YG, Wang ZC, et al. Dietary and lifestyle changes associated with high prevalence of hyperuricemia and gout in the Shandong coastal cities of Eastern China. J Rheumatol. 2008;35:1859–64.

    PubMed  Google Scholar 

  66. Mikkelsen WM, Dodge HJ, Duff IF, Kato H. Estimates of the prevalence of rheumatic diseases in the population of Tecumseh, Michigan, 1959–60. J Chronic Dis. 1967;20:351–69.

    CAS  PubMed  Google Scholar 

  67. Mikuls TR, Farrar JT, Bilker WB, Fernandes S, Schumacher HR, Saag KG. Gout epidemiology: results from the UK general practice research database, 1990–1999. Ann Rheum Dis. 2005;64:267–72.

    PubMed Central  CAS  PubMed  Google Scholar 

  68. Minaur N, Sawyers S, Parker J, Darmawan J. Rheumatic disease in an Australian aboriginal community in North Queensland, Australia. A WHO-ILAR COPCORD survey. J Rheumatol. 2004;31:965–72.

    PubMed  Google Scholar 

  69. Nan HR, Qiao Q, Dong YH, Gao WG, Tang B, Qian RL, et al. The prevalence of hyperuricemia in a population of the coastal city of Qingdao, China. J Rheumatol. 2006;33:1346–50.

    PubMed  Google Scholar 

  70. Obregon-Ponce A, Iraheta I, Garcia-Ferrer H, Mejia B, Garcia-Kutzbach A. Prevalence of musculoskeletal diseases in Guatemala, Central America: the COPCORD study of 2 populations. J Clin Rheumatol. 2012;18:170–4. doi:10.1097/RHU.0b013e3182583803.

    PubMed  Google Scholar 

  71. O’Sullivan JB. Gout in a New England town. A prevalence study in Sudbury, Massachusetts. Ann Rheum Dis. 1972;31:166–9.

    PubMed Central  PubMed  Google Scholar 

  72. Pelaez-Ballestas I, Sanin LH, Moreno-Montoya J, Alvarez-Nemegyei J, Burgos-Vargas R, Garza-Elizondo M, et al. Epidemiology of the rheumatic diseases in Mexico. A study of 5 regions based on the COPCORD methodology. J Rheumatol. 2011;86:3–8. doi:10.3899/jrheum.100951.

    Google Scholar 

  73. Picavet HS, Hazes JM. Prevalence of self reported musculoskeletal diseases is high. Ann Rheum Dis. 2003;62:644–50.

    PubMed Central  CAS  PubMed  Google Scholar 

  74. Popert AJ, Hewitt JV. Gout and hyperuricaemia in rural and urban populations. Ann Rheum Dis. 1962;21:154–63.

    PubMed Central  CAS  PubMed  Google Scholar 

  75. Portis AJ, Laliberte M, Tatman P, Moua M, Culhane-Pera K, Maalouf NM, et al. High prevalence of gouty arthritis among the Hmong population in Minnesota. Arthritis Care Res (Hoboken). 2010;62:1386–91. doi:10.1002/acr.20232.

    Google Scholar 

  76. Prior IA, Rose BS, Harvey HP, Davidson F. Hyperuricaemia, gout, and diabetic abnormality in Polynesian people. Lancet. 1966;1:333–8.

    CAS  PubMed  Google Scholar 

  77. Reyes-Llerena GA, Guibert-Toledano M, Penedo-Coello A, Perez-Rodriguez A, Baez-Duenas RM, Charnicharo-Vidal R, et al. Community-based study to estimate prevalence and burden of illness of rheumatic diseases in Cuba: a COPCORD study. J Clin Rheumatol. 2009;15:51–5.

    PubMed  Google Scholar 

  78. Rose BS, Prior IA. A survey of rheumatism in a rural New Zealand Maori community. Ann Rheum Dis. 1963;22:410–5.

    PubMed Central  CAS  PubMed  Google Scholar 

  79. Salaffi F, De Angelis R, Grassi W. Prevalence of musculoskeletal conditions in an Italian population sample: results of a regional community-based study. I. The MAPPING study. Clin Exp Rheumatol. 2005;23:819–28.

    CAS  PubMed  Google Scholar 

  80. Sari I, Akar S, Pakoz B, Sisman AR, Gurler O, Birlik M, et al. Hyperuricemia and its related factors in an urban population, Izmir, Turkey. Rheumatol Int. 2009;29:869–74.

    PubMed  Google Scholar 

  81. Steven MM. Prevalence of chronic arthritis in four geographical areas of the Scottish Highlands. Ann Rheum Dis. 1992;51:186–94.

    PubMed Central  CAS  PubMed  Google Scholar 

  82. Sullivan FM, Barber JH, Sturrock RD. Rheumatology at the general practitioner/hospital interface: a study of prevalence and access to specialist care. Ann Rheum Dis. 1990;49:983–5.

    PubMed Central  CAS  PubMed  Google Scholar 

  83. Taylor W, Smeets L, Hall J, McPherson K. The burden of rheumatic disorders in general practice: consultation rates for rheumatic disease and the relationship to age, ethnicity, and small-area deprivation. N Z Med J. 2004;117:U1098.

    PubMed  Google Scholar 

  84. Trifiro G, Morabito P, Cavagna L, Ferrajolo C, Pecchioli S, Simonetti M, et al. Epidemiology of gout and hyperuricaemia in Italy during the years 2005–2009: a nationwide population-based study. Ann Rheum Dis. 2012;72:694–700. doi:10.1136/annrheumdis-2011-201254.

    PubMed  Google Scholar 

  85. Veerapen K, Wigley RD, Valkenburg H. Musculoskeletal pain in Malaysia: a COPCORD survey. J Rheumatol. 2007;34:207–13.

    PubMed  Google Scholar 

  86. Wigley R, Manahan L, Muirden KD, Caragay R, Pinfold B, Couchman KG, et al. Rheumatic disease in a Philippine village II: a WHO-ILAR-APLAR COPCORD study, phases II and III. Rheumatol Int. 1991;11:157–61.

    CAS  PubMed  Google Scholar 

  87. Winnard D, Wright C, Taylor WJ, Jackson G, Te Karu L, Gow PJ, et al. National prevalence of gout derived from administrative health data in Aotearoa New Zealand. Rheumatology. 2012;51:901–9. doi:10.1093/rheumatology/ker361.

    PubMed  Google Scholar 

  88. Zalokar J, Lellouch J, Claude JR, Kuntz D. Serum uric acid in 23,923 men and gout in a subsample of 4257 men in France. J Chronic Dis. 1972;25:305–12.

    CAS  PubMed  Google Scholar 

  89. Zeng QY, Wang QW, Chen R, Xiao ZG, Huang SB, Xu JC. Primary gout in Shantou: a clinical and epidemiological study. Chin Med J. 2003;116:66–9.

    PubMed  Google Scholar 

  90. Zhu Y, Pandya BJ, Choi HK. Prevalence of gout and hyperuricemia in the US general population: the National Health and Nutrition Examination Survey 2007–2008. Arthritis Rheum. 2011;63:3136–41. doi:10.1002/art.30520.

    PubMed  Google Scholar 

  91. Zimmet PZ, Whitehouse S, Jackson L, Thoma K. High prevalence of hyperuricaemia and gout in an urbanised Micronesian population. Br Med J. 1978;1:1237–9.

    PubMed Central  CAS  PubMed  Google Scholar 

  92. Lin KC, Lin HY, Chou P. Community based epidemiological study on hyperuricemia and gout in Kin-Hu, Kinmen. J Rheumatol. 2000;27:1045–50.

    CAS  PubMed  Google Scholar 

  93. Arromdee E, Michet CJ, Crowson CS, O’Fallon WM, Gabriel SE. Epidemiology of gout: Is the incidence rising? J Rheumatol. 2002;29:2403–6.

    PubMed  Google Scholar 

  94. Bhole V, de Vera M, Rahman MM, Krishnan E, Choi H. Epidemiology of female gout: 52-Year follow-up of a prospective cohort. Arthritis Rheum. 2010;62:1069–76.

    PubMed  Google Scholar 

  95. Campion EW, Glynn RJ, DeLabry LO. Asymptomatic hyperuricemia. Risks and consequences in the Normative Aging Study. Am J Med. 1987;82:421–6.

    CAS  PubMed  Google Scholar 

  96. Isomaki H, Raunio J, von Essen R, Hameenkorpi R. Incidence of inflammatory rheumatic diseases in Finland. Scand J Rheumatol. 1978;7:188–92.

    CAS  PubMed  Google Scholar 

  97. O’Sullivan JB. The incidence of gout and related uric acid levels in Sudbury, Massachusetts. In: Bennett PH, Wood PHN, editors. Population studies of the rheumatic diseases. Amsterdam: Excerpta Medica; 1968. p. 371–6.

    Google Scholar 

  98. Cea Soriano L, Rothenbacher D, Choi HK, Garcia Rodriguez LA. Contemporary epidemiology of gout in the UK general population. Arthritis Res Ther. 2011;R13:39. doi:10.1186/ar3272.

    Google Scholar 

  99. Robinson P, Taylor W, Merriman T. A systematic review of the prevalence of gout and hyperuricemia in Australia. Intern Med J. 2012;42:997–1007. doi:10.1111/j.1445-5994.2012.02794.x.

    CAS  PubMed  Google Scholar 

  100. Torralba TP, Bayani Sioson PS. The Filipino and gout. Semin Arthritis Rheum. 1975;4:307–20.

    CAS  PubMed  Google Scholar 

  101. Hochberg MC, Thomas J, Thomas DJ, Mead L, Levine DM, Klag MJ. Racial differences in the incidence of gout. The role of hypertension. Arthritis Rheum. 1995;38:628–32.

    CAS  PubMed  Google Scholar 

  102. McAdams MA, Maynard JW, Baer AN, Kottgen A, Clipp S, Coresh J, et al. Reliability and sensitivity of the self-report of physician-diagnosed gout in the campaign against cancer and heart disease and the atherosclerosis risk in the community cohorts. J Rheumatol. 2011;38:135–41. doi:10.3899/jrheum.100418.

    PubMed Central  PubMed  Google Scholar 

Download references

Conflict of interest

The authors have no conflict of interest associated with the work reported in this paper.

Author information

Authors and Affiliations

  1. Division of Rheumatology, Department of Internal Medicine, Maastricht University Medical Center, P.O. Box 5800, 6202 AZ, Maastricht, The Netherlands

    José M. A. Wijnands, Kristof Thevissen, Sjef van der Linden & Annelies Boonen

  2. School for Public Health and Primary Care (CAPHRI), Maastricht University, Maastricht, The Netherlands

    José M. A. Wijnands, Ilja C. W. Arts, Pieter C. Dagnelie, Sjef van der Linden & Annelies Boonen

  3. Department of Psychiatry and Psychology, Maastricht University, Maastricht, The Netherlands

    Wolfgang Viechtbauer

  4. CARIM School for Cardiovascular Diseases, Maastricht University, Maastricht, The Netherlands

    Ilja C. W. Arts, Pieter C. Dagnelie & Coen D. A. Stehouwer

  5. Department of Epidemiology, Maastricht University, Maastricht, The Netherlands

    Ilja C. W. Arts & Pieter C. Dagnelie

  6. Department of Internal Medicine, Maastricht University Medical Center, Maastricht, The Netherlands

    Coen D. A. Stehouwer

Authors
  1. José M. A. Wijnands
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Wolfgang Viechtbauer
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Kristof Thevissen
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ilja C. W. Arts
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Pieter C. Dagnelie
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Coen D. A. Stehouwer
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Sjef van der Linden
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Annelies Boonen
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to José M. A. Wijnands.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOC 284 kb)

Supplementary material 2 (DOC 120 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wijnands, J.M.A., Viechtbauer, W., Thevissen, K. et al. Determinants of the prevalence of gout in the general population: a systematic review and meta-regression. Eur J Epidemiol 30, 19–33 (2015). https://doi.org/10.1007/s10654-014-9927-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10654-014-9927-y

Keywords

Search

Navigation